Design of a Randomized Controlled Clinical Study of tissue-engineered osteogenic materials using bone marrow-derived mesenchymal cells for Maxillomandibular bone defects in Japan: the TEOM study protocol

Design of a Randomized Controlled Clinical Study of tissue-engineered osteogenic materials using bone marrow-derived mesenchymal cells for Maxillomandibular bone defects in Japan: the TEOM study protocol

Abstract Background Maxillomandibular bone defects arise from maxillofacial injury or tumor/cyst removal. While the standard therapy for bone regeneration is transplantation with autologous bone or artificial bone, these therapies are still unsatisfactory. Autologous bone harvesting is invasive and...

Full description

Bibliographic Details
Main Authors: Shinobu Shimizu, Shuhei Tsuchiya, Akihiro Hirakawa, Katsuyoshi Kato, Masahiko Ando, Masaaki Mizuno, Masashi Osugi, Kazuto Okabe, Wataru Katagiri, Hideharu Hibi
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Oral Health
Subjects:
Tissue engineering
Regenerative medicines
Cell therapy
Bone marrow cells
Cell transplantation
Bone
Online Access:http://link.springer.com/article/10.1186/s12903-019-0753-1

Internet

http://link.springer.com/article/10.1186/s12903-019-0753-1

Similar Items